Fetal programming of COVID-19: May the barker hypothesis explain the susceptibility of a subset of young adults to develop severe disease?

Clara Gerosa, G. Faa, D. Fanni, M. Manchia, J. S. Suri, A. Ravarino, D. Barcellona, G. Pichiri, P. Coni, T. Congiu, M. Piras, G. Cerrone, F. Cau, F. Ledda, V. Aimola, F. Coghe, M. Porcu, R. Cau, G. Orru', P. Van EykenG. La Nasa, M. Castagnola, F. Marongiu, L. Saba

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

21 Citas (Scopus)

Resumen

The risk stratification of young adults between subjects who will develop a mild form COVID-19 and subjects who will undergo a severe disease remains inaccurate. In this review, we propose that the Barker hypothesis might explain the increased susceptibility to severe forms of COVID-19 in subjects who underwent intrauterine growth restriction (IUGR). In this paper evidence indicating an association between a low birth weight and an adult phenotype which might favor a severe outcome of SARS-CoV-2 infection are presented: lower lung functional capacity; increased respiratory morbidity; changes in fibrinogen and Factor VII serum levels and dysregulation of the hemostasis and thrombosis system; acquisition of a pro-thrombotic phenotype; low nephron number, with decreased ability to sustain renal function and increased renal morbidity; heart remodeling, with a less efficient cardiac function; endothelial dysfunction, a risk factor for the insurgence of the multiple organ failure; remodeling of arteries, with changes in the elastic properties of the arterial wall, predisposing to the insurgence and progression of atherosclerosis; dysfunction of the innate immune system, a risk factor for immune diseases in adulthood. These data suggest that young and adult subjects born too small (IUGR) or too early (pre-terms) might represent a subgroup of "at risk subjects", more susceptible toward severe forms of COVID-19. Given that LBW may be considered a surrogate of IUGR, this phenotypic marker should be included among the indispensable clinical data collected in every patient presenting with SARSCOV- 2 infection, irrespectively of his/her age.

Idioma originalEnglish
Páginas (desde-hasta)5876-5884
Número de páginas9
PublicaciónEuropean Review for Medical and Pharmacological Sciences
Volumen25
N.º18
DOI
EstadoPublished - 2021

Nota bibliográfica

Publisher Copyright:
© 2021 Verduci Editore s.r.l. All rights reserved.

ASJC Scopus Subject Areas

  • Pharmacology (medical)

PubMed: MeSH publication types

  • Journal Article
  • Review

Huella

Profundice en los temas de investigación de 'Fetal programming of COVID-19: May the barker hypothesis explain the susceptibility of a subset of young adults to develop severe disease?'. En conjunto forman una huella única.

Citar esto

Gerosa, C., Faa, G., Fanni, D., Manchia, M., Suri, J. S., Ravarino, A., Barcellona, D., Pichiri, G., Coni, P., Congiu, T., Piras, M., Cerrone, G., Cau, F., Ledda, F., Aimola, V., Coghe, F., Porcu, M., Cau, R., Orru', G., ... Saba, L. (2021). Fetal programming of COVID-19: May the barker hypothesis explain the susceptibility of a subset of young adults to develop severe disease? European Review for Medical and Pharmacological Sciences, 25(18), 5876-5884. https://doi.org/10.26355/eurrev_202109_26810